Biothrax: Clinical Trials

4 trials of Biothrax, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Biothrax: new trials by email Literature Review of Biothrax trials Research Report on Biothrax

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
BW-1010: 50 µg - sprayer - IN, BW-1010: 50 µg - pipette - IN, BW-1010: 100 µg - sprayer - IN - Anthrax
Phase 1CompletedBlueWillow Biologics842020-01-082022-05-18
NasoShield Study of Safety and Immunogenicity
NasoShield, BioThrax, Placebo - Healthy Volunteers
Phase 1CompletedAltimmune, Inc.1452018-01-182025-06-24
A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines
AVA, Ad4-PA-1, Ad4-PA-GPI-1 - Anthrax Infection
Phase 1CompletedEmergent BioSolutions1202013-11-012024-03-18
Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
BioThrax, AV7909 Formulation 1, AV7909 Formulation 2 - Bacillus Anthracis (Anthrax) Infection
Phase 1CompletedEmergent BioSolutions1052010-12-012024-03-18

Conditions studied

Anthrax (4)  ·  Infections (1)

Sponsors

Emergent BioSolutions (2)  ·  Altimmune, Inc. (1)  ·  BlueWillow Biologics (1)

Countries

United States (4)

Top investigators

Edward Bernton, MD (1)  ·  Emanuel DeNoia, MD (1)  ·  Jakub Simon, MD (1)  ·  Marc Gurwith, MD (1)  ·  Mo Elsafy, MD, MSc (1)

Results publications

PMID 23701746